Download 
|
< Back |
| 05 Feb 2025 | |
| 1.) Considered and approved Un-audited financial results for the quarter and nine months ended on 31st December 2024. 2.) The board has considered and approved the appointment of Mr. Kelash Bunkar as Whole-time Director and Chief Financial Officer of the Company w.e.f 05.02.2025. 3.) The board has considered and accepted the resignation of Mr. Niraj Vaghela from designation of Whole time Director and Chief Financial Officer of the Company w.e. f 05.02.2025 4.) Mr. Aman Patel is appointed as non-executive independent director of the company w .e. f. 05.02.2025 subject to approval of members. 5.) The board has considered and accepted the of Independent Director Ms Komal Chauhan w e.f 05.02.2025. The board meeting commenced at 03:30 PM and concluded at 04:25 PM | |
| View all announcements for Biogen Pharmachem Industries Ltd | Source: BSE India |
© 2026 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback